Development and validation of a high performance liquid chromatography‐tandem mass spectrometric method for simultaneous determination of bupropion, quetiapine, and escitalopram in human plasma

Schizophrenia is one of the most debilitating and costly illnesses worldwide. First-generation antipsychotics such as chlorpromazine and haloperidol succeeded in controlling the positive symptoms of schizophrenia, but had significant extrapyramidal effects that led to the search for new agents and the release of second-generation (or atypical) antipsychotics. These drugs had a lower risk of adverse motor symptoms. Therapeutic drug monitoring has become a useful tool to optimize schizophrenia treatment and HPLC–MS/MS has been considered the primary technique to monitor antipsychotics. This review comprises three sections: schizophrenia pathophysiology and treatment; recent advances in LC–MS/MS methods designed to measure levels of antipsychotics and their metabolites in plasma samples (selectivity, matrix effect and sensitivity); and the importance of therapeutic drug monitoring.

show abstract

Schizophrenia: Recent Advances in LC–MS/MS Methods to Determine Antipsychotic Drugs in Biological Samples

Queiroz

Pinto

Cruz

et al. 2019

Bioanalysis

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Development and validation of a high performance liquid chromatography‐tandem mass spectrometric method for simultaneous determination of bupropion, quetiapine, and escitalopram in human plasma

Abstract: Shin SC. Development and validation of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous determination of bupropion, quetiapine and escitalopram in human plasma. Biomedical Chromatography 2015; 29: 612-618.

Cited by 1 publication

References 1 publication

Schizophrenia: Recent Advances in LC–MS/MS Methods to Determine Antipsychotic Drugs in Biological Samples

Schizophrenia: Recent Advances in LC–MS/MS Methods to Determine Antipsychotic Drugs in Biological Samples

Contact Info

Product

Resources

About